Our Products

Our products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. More

Research & Growth

We recognize the immense value of clinical research and are committed to investing in it to expand the body of knowledge in our therapeutic areas and advance potential future health innovations for patients. More

AMAG Corporate Principles

Our company values provide an important framework for who we are and how we operate. AMAG is also committed to a set of corporate principles that guide how we pursue our business goals and deliver on our promise to patients and their families. More

News

AMAG Announces First Patient Enrolled in Phase 2b/3a Digoxin Immune Fab Study...

AMAG Announces First Patient Enrolled in Phase 2b/3a Digoxin Immune Fab Study Conducted by Velo Bio

WALTHAM, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Velo Bio, LLC has enrolled the first patient More

Working at AMAG

“AMAG has a diverse culture of intelligent, fun people, who are encouraged by a leadership team that rewards innovation and improvement.”

Michelle Murphy
Senior Compliance Specialist